Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line

Journal of Neuroimmunology

Volumn 79, Issue 1, 1997, Pages 12-21

  Matera, Lina ^a   Cutufia, Miguel ^b   Geuna, Massimo ^b   Contarini, Maria ^a   Buttiglieri, Stefano ^a   Galin, Shawn ^c   Fazzari, Annamaria ^b   Cavaliere, Cristina ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Immunomodulation; Jurkat cell line; Leukemic cells; Prolactin

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 2 RECEPTOR; METHIONINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; PROLACTIN; PROLACTIN RECEPTOR; RECOMBINANT INTERLEUKIN 2; RECOMBINANT PROTEIN; SULFUR 35;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SYNTHESIS; RAT;

ANIMALS; ANTIBODIES; CELL DIVISION; CHEMISTRY; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LEUKEMIA, T-CELL; PROLACTIN; RATS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, PROLACTIN;

EID: 0030659717     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00096-9     Document Type: Article

References (40)

1. Ali S., Pellegrini I., Kelly P.A. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J. Biol. Chem. 266:1991;20110-20117.
2. Baglia L.A., Cruz D., Shaw J.E. An Epstein-Barr virus-negative burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continous growth in serum-free medium. Endocrinology. 128:1991;2266-2272.
3. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA. 87:1990;6934-6938.
4. Bellone G., Geuna M., Carbone A., Silvestri S., Foa R., Emanuelli G., Matera L. Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells. J. Cell. Physiol. 163:1995;221-231.
5. Cesano A., Oberholtzer E., Contarini M., Geuna M., Bellone G., Matera L. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology. 28:1994;67-75.
6. Clevenger C.V., Russell D.H., Appasamy P.M., Prystowsky M.B. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. 87:1990;6460-6464.
7. Clevenger C.V., Sillman A.L., Hanley-Hyde J., Prystowsky M.B. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology. 130:1992;3216-3222.
8. Croze F., Walker A., Friesen H.G. Stimulation of growth of Nb2 lymphoma cells by interleukin-2 in serum-free and serum-containing media. Mol. Cell. Endocrinol. 55:1988;253-259.
9. Dardenne M., Leite de Moraes M.C., Kelly P.A., Gagnerault M.C. Prolactin receptor expression in human hemopoietic tissues analyzed by flow cytofluorimetry. Endocrinology. 134:1994;2108-2114.
10. Di Mattia G.E., Gellersen B., Bohnet H.G., Friesen H.G. A human B-lymphoblastoid cell line produces prolactin. Endocrinology. 122:1988;2508-2518.
11. Friesen H.G., Di Mattia G.E., Too C.K.L. Lymphoid tumor cells as models for studies of prolactin gene expression and action. Prog. Neuroendocrinol. Immunol. 4:1991;1-12.
12. Fuh G., Colosi P., Wood W.J., Wells J.A. Mechanism-based design of prolactin receptor antagonists. J. Biol. Chem. 268:1993;5376-5381.
13. Gala R.R. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198:1991;513-527.
14. Gellersen B., Di Mattia G.E., Friesen H.G., Bohnet H.G. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinol. 125:1989;2853-2861.
15. Giegel J.L., Brotherton M.M., Cronin P., D'Aquino M., Evans S., Heller Z.H., Knight W.S., Krishnan K., Shelman M. Radial partition immunoassay. Clin. Chem. 28:1982;1891-1894.
16. Gillis S., Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an Interleukin-2 producing human leukemia T cell line. J. Exp. Med. 152:1980;1709-1714.
17. Gilmour K.C., Reich N.C. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proc. Natl. Acad. Sci. USA. 91:1994;6850-6854.
18. Gutierrez M.A., Molina G.F., Jara L.J., Garcin C., Gutierrezurena S., Cuellar M.L., Gharavi A., Espinoza L.R. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int. Arch. Allerg. Immunol. 109:1996;229-235.
19. Hartmann D., Holaday J., Bernton E. Inhibition of lymphocyte proliferation by Abs to PRL. FASEB J. 3:1989;2194-2202.
20. Hooghe R., Delhase, Vergani M., Malur A., Hooghe-Peters E.L. Growth hormone and prolactin are paracrine growth and differentiating factors in the haemopoietic system. Immunol. Today. 14:1993;212-214.
21. Hou J., Schindler U., Henzel W.J., Wong S.C., McKnigth S.L. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity. 2:1995;321-329.
22. Krown K.A., Wang Y.F., Walker A.M. Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology. 124:1994;1546-1554.
23. Matera L., Muccioli G., Cesano A., Bellussi G., Gennazzani E. Prolactin receptors on Large Granular Lymphocytes: Dual regulation by Cyclosporin A. Brain Behav. Immun. 2:1988;1-10.
24. Matera L., Cesano A., Muccioli G., Veglia F. Modulatory effect of prolactin on DNA synthesis rate and NK activity of Large Granular Lymphocytes. Int. J. Neurosci. 51:1990;265-267.
25. Matera L., Cesano A., Bellone G., Oberholtzer E. Modulatory effect of Prolactin on the resting and mitogen-induced activity of T, B and NK lymphocytes. Brain Behav. Immun. 6:1992;409-417.
26. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci. 59:1996;599-614.
27. Matera L., Bellone G., Lebrun J.J., Kelly P.A., Hooghe-Peters E.L., Francia Di Celle P., Foa R., Contarini M., Avanzi G., Asnaghi V. Role of prolactin in the in vitro development of IL-2-driven anti-tumoral lymphokine activated killer cells. Immunology. 89:1996;619-626.
28. Minamoto S., Mori H., Hartakeyama M., Kono T., Doi T., Ide T., Uede T., Taniguchi T. Characterization of the heterodimeric complex of human IL-2 receptor α-β chains reconstituted in a mouse fibroblast cell line, L929. J. Immunol. 145:1990;2177-2182.
29. Montgomery D.W., Shen G.K., Ulrich E.D., Steiner L.L., Parrish P.R., Zukoski C.F. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology. 131:1992;3019-3026.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-64.
31. Mukherjee P., Mastro A.M., Hymer W.C. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology. 126:1990;88-94.
32. Pedersen-Bjergaard J., Philip P., Larsen P., Jensen S.O., Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood. 76:1990;1083-1091.
33. Pellegrini I., Lebrun J.J., Ali S., Kelly P.A. Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6:1992;1023-1031.
34. Russell D.H., Kibler R., Matrisian L., Larson D.F., Poulos B., Magun B.E. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding to cyclosporin. J. Immunol. 134:1985;3027-3031.
35. Sabarwal P., Glaser R., Lafuse W., Varma S., Liu Q., Arkins S., Kooijman R., Kutz L., Kelley R.W., Malarkey W.B. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. USA. 89:1992;7713-7716.
36. Sissom J.F., Eigenbrodt M.L., Porter J.C. Anti-growth action on mouse mammary and prostate glands of a monoclonal Ab to prolactin receptor. Am. J. Pathol. 133:1988;589-595.
37. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: A current overview. Cell. 73:1993;5-8.
38. Viselli S.M., Stanek E.M., Mukherjee P., Hymer W.C., Mastro A.M. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology. 129:1991;983-990.
39. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. Pharmacol. Ther. 69:1996;237-257.
40. Winkelmann J.C., Ward J., Mayeux P., Lacombe C., Schimmenti L., Jenkins R.B. A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein. Blood. 85:1995;179-185.